FDG-PET and radiotherapy in lymphoma

Umberto Ricardi; Lena Specht; Annibale Versari; Anne Kiil Berthelsen

doi:10.1007/s40336-015-0129-8

FDG-PET and radiotherapy in lymphoma

Umberto Ricardi, Lena Specht, Annibale Versari, Anne Kiil Berthelsen

Arcispedale Santa Maria Nuova

Research output: Contribution to journal › Article › peer-review

Abstract

Most lymphoma types are fluorodeoxyglucose positron emission tomography (FDG-PET) positive, and FDG-PET/computed tomography (CT) is used routinely in staging and treatment evaluation of lymphomas. PET/CT imaging is important for contouring of the target for radiotherapy and changes the radiation volumes significantly compared with radiotherapy planning based on CT alone. Modern advanced imaging techniques with image fusion and inspiration breath hold have enabled further refinements of radiotherapy for lymphoma, reducing the risks of long-term side effects while maintaining the high cure rate for these diseases.

Original language	English
Pages (from-to)	321-330
Number of pages	10
Journal	Clinical and Translational Imaging
Volume	3
Issue number	4
DOIs	https://doi.org/10.1007/s40336-015-0129-8
Publication status	Published - Aug 26 2015

Keywords

Breath hold
Image fusion
Lymphoma
PET/CT
Radiotherapy

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1007/s40336-015-0129-8

Cite this

@article{9366c99546ed428aa83b75a803c940ee,

title = "FDG-PET and radiotherapy in lymphoma",

abstract = "Most lymphoma types are fluorodeoxyglucose positron emission tomography (FDG-PET) positive, and FDG-PET/computed tomography (CT) is used routinely in staging and treatment evaluation of lymphomas. PET/CT imaging is important for contouring of the target for radiotherapy and changes the radiation volumes significantly compared with radiotherapy planning based on CT alone. Modern advanced imaging techniques with image fusion and inspiration breath hold have enabled further refinements of radiotherapy for lymphoma, reducing the risks of long-term side effects while maintaining the high cure rate for these diseases.",

keywords = "Breath hold, Image fusion, Lymphoma, PET/CT, Radiotherapy",

author = "Umberto Ricardi and Lena Specht and Annibale Versari and Berthelsen, {Anne Kiil}",

year = "2015",

month = aug,

day = "26",

doi = "10.1007/s40336-015-0129-8",

language = "English",

volume = "3",

pages = "321--330",

journal = "Clinical and Translational Imaging",

issn = "2281-5872",

publisher = "Springer-Verlag Italia s.r.l.",

number = "4",

}

TY - JOUR

T1 - FDG-PET and radiotherapy in lymphoma

AU - Ricardi, Umberto

AU - Specht, Lena

AU - Versari, Annibale

AU - Berthelsen, Anne Kiil

PY - 2015/8/26

Y1 - 2015/8/26

N2 - Most lymphoma types are fluorodeoxyglucose positron emission tomography (FDG-PET) positive, and FDG-PET/computed tomography (CT) is used routinely in staging and treatment evaluation of lymphomas. PET/CT imaging is important for contouring of the target for radiotherapy and changes the radiation volumes significantly compared with radiotherapy planning based on CT alone. Modern advanced imaging techniques with image fusion and inspiration breath hold have enabled further refinements of radiotherapy for lymphoma, reducing the risks of long-term side effects while maintaining the high cure rate for these diseases.

AB - Most lymphoma types are fluorodeoxyglucose positron emission tomography (FDG-PET) positive, and FDG-PET/computed tomography (CT) is used routinely in staging and treatment evaluation of lymphomas. PET/CT imaging is important for contouring of the target for radiotherapy and changes the radiation volumes significantly compared with radiotherapy planning based on CT alone. Modern advanced imaging techniques with image fusion and inspiration breath hold have enabled further refinements of radiotherapy for lymphoma, reducing the risks of long-term side effects while maintaining the high cure rate for these diseases.

KW - Breath hold

KW - Image fusion

KW - Lymphoma

KW - PET/CT

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84952993788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952993788&partnerID=8YFLogxK

U2 - 10.1007/s40336-015-0129-8

DO - 10.1007/s40336-015-0129-8

M3 - Article

AN - SCOPUS:84952993788

VL - 3

SP - 321

EP - 330

JO - Clinical and Translational Imaging

JF - Clinical and Translational Imaging

SN - 2281-5872

IS - 4

ER -

FDG-PET and radiotherapy in lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this